Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2015-02-28
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Diagnosing dementia requires a comprehensive assessment, an essential component of which is a cognitive assessment tool, which takes the form of a questionnaire. In clinical practice, this is currently only available through the medium of English.
The investigators objective is to measure the difference between Cognitive Assessment scores (using the Montreal cognitive assessment (MoCA)), when done in English and Welsh, in those who are cognitively impaired and whose first language is Welsh. The investigators predict that there will be a significant difference in scores in favour of the Welsh-medium tests, thus proving that the current mode of administering the test is prejudiced against patients whose first language is Welsh.
If the investigators predictions are correct, then the investigators would seek to introduce a validated Welsh-language cognitive assessment tool to the domain of the Welsh NHS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
UK Validation of the Automated "AcceXible" Speech Analysis Software
NCT05534958
Cohort Study on Cognitive Decline in Elderly
NCT07093892
Brief Assessment of Impaired Cognition
NCT04304859
Validation of acceXible's Automated Speech Analysis Method for the Early Detection and Monitoring of Patients With Mild Impairment or Dementia in Primary Care
NCT05380297
Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease
NCT03672279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Welsh
Participants will complete the cognitive assessment in Welsh and in English these will be compared to assess whether first language Welsh speakers perform better in Welsh.
Welsh language Cognitive Assessment
This intervention may intervene by displaying a more realisitic reflection of the patient's cognitive ability by assessing the patient in their first language
English
Participants will complete the cognitive assessment in Welsh and in English these will be compared to assess whether first language Welsh speakers perform better in Welsh.
Welsh language Cognitive Assessment
This intervention may intervene by displaying a more realisitic reflection of the patient's cognitive ability by assessing the patient in their first language
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Welsh language Cognitive Assessment
This intervention may intervene by displaying a more realisitic reflection of the patient's cognitive ability by assessing the patient in their first language
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Dementia - recorded in patient's case notes
Exclusion Criteria
* Intercurrent illness
* Blind/any other disability which may prevent participant from fully completing Cognitive Assessment
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Betsi Cadwaladr University Health Board
OTHER_GOV
Conor Martin
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Conor Martin
Dr Conor Martin
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sion Jones, MBBCh
Role: PRINCIPAL_INVESTIGATOR
BCUHB NHS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ysbyty Glan Clwyd
Bodelwyddan, Denbighshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Cummings JL, Benson F, Hill MA, Read S. Aphasia in dementia of the Alzheimer type. Neurology. 1985 Mar;35(3):394-7. doi: 10.1212/wnl.35.3.394.
Mendez MF, Perryman KM, Ponton MO, Cummings JL. Bilingualism and dementia. J Neuropsychiatry Clin Neurosci. 1999 Summer;11(3):411-2. doi: 10.1176/jnp.11.3.411. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BCUHB - PS - CAWS - 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.